These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 11185685

  • 1. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.
    Toth K, Nemes J, Czopf L, Kapronczay P, Kesmarky G, Juricskay I.
    Clin Hemorheol Microcirc; 1999; 20(1):57-61. PubMed ID: 11185685
    [Abstract] [Full Text] [Related]

  • 2. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K, Kesmarky G, Vekasi J, Nemes J, Czopf L, Kapronczay P, Halmosi R, Papp E, Juricskay I.
    Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
    [Abstract] [Full Text] [Related]

  • 3. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y, Satoh K, Kitadai M, Izumi Y, Takahashi T.
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [Abstract] [Full Text] [Related]

  • 4. Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity.
    Muravyov AV, Meiselman HJ, Yakusevich VV, Zamishlayev AV.
    Clin Hemorheol Microcirc; 2002 Aug; 26(2):125-35. PubMed ID: 12082261
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 6. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism].
    Sznajderman M, Chotkowska E, Peczkowska M, Sawicki M, Janaszek-Sitkowska H, Wiernikowska-Wegorek I, Galewicz A, Cybulska I.
    Kardiol Pol; 1993 Feb; 38(2):107-11. PubMed ID: 8230980
    [Abstract] [Full Text] [Related]

  • 7. [Hemorheologic changes in patients with essential hypertension treated with prazosin].
    Gerc V, Koblar V, Brkić D, Kamhi J.
    Med Pregl; 1992 Feb; 45(7-8):285-7. PubMed ID: 1344459
    [Abstract] [Full Text] [Related]

  • 8. The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients.
    Muravyov AV, Yakusevich VV, Surovaya L, Petrochenko A.
    Clin Hemorheol Microcirc; 2004 Feb; 31(4):251-6. PubMed ID: 15567894
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hemorheologic factors in hypertensive and diabetic retinopathy].
    Vékási J, Márton Z, Késmárky G, Cser A, Russai R, Kovács B.
    Orv Hetil; 2001 May 20; 142(20):1045-8. PubMed ID: 11407065
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
    Calvo C, Gil-Extremera B, Gomez-Fernández P, Masramon X, Pueyo C, Armada B.
    Int J Cardiol; 2005 May 11; 101(1):97-104. PubMed ID: 15860390
    [Abstract] [Full Text] [Related]

  • 14. Gender differences in hemorheological parameters of coronary artery disease patients.
    Bogar L, Juricskay I, Kesmarky G, Feher G, Kenyeres P, Toth K.
    Clin Hemorheol Microcirc; 2006 May 11; 35(1-2):99-103. PubMed ID: 16899912
    [Abstract] [Full Text] [Related]

  • 15. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G, Koltai K, Kesmarky G, Horvath B, Toth K, Komoly S, Szapary L.
    Phytomedicine; 2009 Mar 11; 16(2-3):111-7. PubMed ID: 19135345
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hemorheological investigations in patients with polycystic kidney disease.
    Shand BI.
    Clin Hemorheol Microcirc; 2002 Mar 11; 27(1):13-6. PubMed ID: 12237486
    [Abstract] [Full Text] [Related]

  • 19. Effect of antihypertensive treatment with doxazosin on insulin sensitivity and fibrinolytic parameters.
    Zehetgruber M, Christ G, Gabriel H, Mundigler G, Beckmann R, Binder BR, Huber K.
    Thromb Haemost; 1998 Feb 11; 79(2):378-82. PubMed ID: 9493594
    [Abstract] [Full Text] [Related]

  • 20. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
    Szapáry L, Horváth B, Alexy T, Márton Z, Késmárky G, Szóts M, Nagy F, Czopf J, Tóth K.
    Orv Hetil; 2003 May 18; 144(20):973-8. PubMed ID: 12830727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.